StockData
Mesoblast Ltd logo

Mesoblast Ltd (MESO) income statement

MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 27, 2026Score 6/30
$10.89−0.29 (-2.59%)

Close on Nov 20, 2026Market cap $1.41BP/E –Yield –

See a number that looks wrong?